Acute Myelogenous Leukemia (AML)
Showing 1 - 25 of >10,000
Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)
Completed
- Acute Myelogenous Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 4, 2023
Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous
Recruiting
- Breast Cancer
- +4 more
- Web bases survey
-
Canton, OhioCleveland Clinic Mercy Hospital
Aug 2, 2023
Acute Myelogenous Leukemia (AML) Trial in Australia (MAX-40279)
Recruiting
- Acute Myelogenous Leukemia (AML)
-
Darlinghurst, New South Wales, Australia
- +3 more
Jan 18, 2022
Pediatric Acute Myelogenous Leukemia (AML) Trial in Australia, Canada, United States (Decitabine)
Terminated
- Pediatric Acute Myelogenous Leukemia (AML)
-
Phoenix, Arizona
- +21 more
Jun 24, 2022
Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous
Recruiting
- Breast Cancer
- +4 more
- Web based survey
-
New Haven, Connecticut
- +6 more
Aug 8, 2023
Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +2 more
- RD13-02 cell infusion
-
Xuzhou, Jiangsu, ChinaAffiliated hospital of Xuzhou medical college
Jun 7, 2023
AML Trial in Hangzhou (MAX-40279-01)
Recruiting
- AML
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Jan 18, 2022
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,
Terminated
- Acute Myelogenous Leukemia
- +2 more
- Fenretinide
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Mar 17, 2022
Acute Myelogenous Leukemia (AML) Trial in Philadelphia (Eltrombopag)
Terminated
- Acute Myelogenous Leukemia (AML)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jul 14, 2021
Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States
Recruiting
- Acute Myelogenous Leukemia (AML)
- +5 more
- Conditioning Chemotherapy
- Cord blood graft
-
Basking Ridge, New Jersey
- +6 more
May 22, 2023
Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)
Completed
- Acute Myelogenous Leukemia
- +3 more
-
Miami, FloridaUniversity of Miami
Dec 7, 2021
MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
- Acute Myelogenous Leukemia (AML)
- low dose 5'-azacitidine
-
Basking Ridge, New Jersey
- +6 more
Dec 1, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022
Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,
Terminated
- Leukemia
- +2 more
- Ciprofloxacin 750 MG
- +3 more
-
Gainesville, FloridaUF Health Shands Cancer Hospital
Jul 5, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)
Terminated
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Duarte, California
- +4 more
Sep 14, 2021
Acute Myeloid Leukemia Trial in Ramat Gan (CAR-T CD19)
Recruiting
- Acute Myeloid Leukemia
- CAR-T CD19
-
Ramat Gan, IsraelChaim Sheba Medical Center
Oct 30, 2022
Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in
Terminated
- Acute Myelogenous Leukemia in Relapse
- +4 more
-
Tucson, Arizona
- +12 more
Aug 18, 2022
Acute Myeloid Leukemia Trial in Toronto (IL-12)
Recruiting
- Acute Myeloid Leukemia
- IL-12
-
Toronto, Ontario, CanadaPrincess Margaret Centre Centre
Apr 16, 2021
Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Leipzig, GermanyUniversitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)
Terminated
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Boston, Massachusetts
- +5 more
Jun 11, 2021
Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)
Active, not recruiting
- Acute Myelogenous Leukemia
- AML
- DC AML Vaccine
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 25, 2022
Acute Myelogenous Leukemia Trial in Rochester (Decitabine)
Completed
- Acute Myelogenous Leukemia
-
Rochester, New YorkUniversity of Rochester
Jul 1, 2022
AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)
Recruiting
- AML
- +4 more
- CD123-CAR T
- +4 more
-
Memphis, Tennessee
- +1 more
May 10, 2022
Venetoclax Tablets Crushed and Dissolved Into a Solution
Not yet recruiting
- Hematologic Malignancy
- +18 more
- 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 8, 2023